These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37884479)

  • 1. A Gene-Editable Palladium-Based Bioorthogonal Nanoplatform Facilitates Macrophage Phagocytosis for Tumor Therapy.
    Feng S; Zhang Y; Gao Y; Liu Y; Wang Y; Han X; Zhang T; Song Y
    Angew Chem Int Ed Engl; 2023 Dec; 62(50):e202313968. PubMed ID: 37884479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional anisotropic palladium nanozymes reprogram macrophages to enhance collaborative chemodynamic therapy of colorectal cancer.
    Chen X; Jia Z; Wen Y; Huang Y; Yuan X; Chen Y; Liu Y; Liu J
    Acta Biomater; 2022 Oct; 151():537-548. PubMed ID: 35981687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.
    Sakakura K; Takahashi H; Kaira K; Toyoda M; Murata T; Ohnishi H; Oyama T; Chikamatsu K
    Lab Invest; 2016 Sep; 96(9):994-1003. PubMed ID: 27322955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
    Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
    J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
    Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
    Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Bacterial Outer Membrane Vesicles as Controllable Two-Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy.
    Feng Q; Ma X; Cheng K; Liu G; Li Y; Yue Y; Liang J; Zhang L; Zhang T; Wang X; Gao X; Nie G; Zhao X
    Adv Mater; 2022 Oct; 34(40):e2206200. PubMed ID: 35985666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric Peptide Engineered Bioregulator for Metastatic Tumor Immunotherapy through Macrophage Polarization and Phagocytosis Restoration.
    Chen XY; Yan MY; Liu Q; Yu BX; Cen Y; Li SY
    ACS Nano; 2023 Aug; 17(16):16056-16068. PubMed ID: 37578051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulant Hydrogel-Guided Tumor Microenvironment Reprogramming to Efficiently Potentiate Macrophage-Mediated Cellular Phagocytosis for Systemic Cancer Immunotherapy.
    Liang JL; Jin XK; Luo GF; Zhang SM; Huang QX; Lin YT; Deng XC; Wang JW; Chen WH; Zhang XZ
    ACS Nano; 2023 Sep; 17(17):17217-17232. PubMed ID: 37584451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Biomimetic Nanogel System Restores Macrophage Phagocytosis for Magnetic Resonance Imaging-Guided Synergistic Chemoimmunotherapy of Breast Cancer.
    Li L; Gao Y; Zhang Y; Yang R; Ouyang Z; Guo R; Yu H; Shi X; Cao X
    Adv Healthc Mater; 2023 Oct; 12(26):e2300967. PubMed ID: 37470683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
    Zhang M; Hutter G; Kahn SA; Azad TD; Gholamin S; Xu CY; Liu J; Achrol AS; Richard C; Sommerkamp P; Schoen MK; McCracken MN; Majeti R; Weissman I; Mitra SS; Cheshier SH
    PLoS One; 2016; 11(4):e0153550. PubMed ID: 27092773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
    Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
    Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
    Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy.
    Cao A; Yi J; Tang X; Szeto CW; Wu R; Wan B; Fang X; Li S; Wang L; Wang L; Li J; Ye Q; Huang T; Hsu K; Kabbarah O; Zhou H
    Cancer Res Commun; 2022 Nov; 2(11):1404-1417. PubMed ID: 36970051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention.
    Zhou X; Liu X; Huang L
    Adv Funct Mater; 2021 Jan; 31(5):. PubMed ID: 33692665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment.
    Sun K; Yu J; Hu J; Chen J; Song J; Chen Z; Cai Z; Lu Z; Zhang L; Wang Z
    Acta Biomater; 2022 Aug; 148():230-243. PubMed ID: 35724919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy.
    Zheng C; Zhong Q; Yi K; Kong H; Cao F; Zhuo C; Xu Y; Shi R; Ju E; Song W; Tao Y; Chen X; Li M
    Sci Adv; 2023 Aug; 9(32):eadh2413. PubMed ID: 37556535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression.
    Sun Y; Xiao W; Yu Y; Jiang Y; Xiao Z; Huang D; Zhong T; Li J; Xiang X; He Y; Li Z
    Exp Cell Res; 2023 May; 426(2):113565. PubMed ID: 36958650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2-Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy.
    Zhao W; Hu X; Li W; Li R; Chen J; Zhou L; Qiang S; Wu W; Shi S; Dong C
    Small; 2021 Apr; 17(13):e2007051. PubMed ID: 33599061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.